7.3.4 RGN-259 125 7.3.5 Cis-UCA 131 7.3.6 SI-614 133 7.4 Promising Drugs in Early-Stage Development 134 7.4.1 KPI-121 134 7.4.2 Ozagrel 135 7.4.3 P-321 136 7.4.4 Dextenza ( OTX-DP ) 137 7.5 Other Drugs in Development 138
8 Market Outlook 139 8.1 China 139 8.1.1 Forecast 139
Browse Complete Summary Click Here @ http :// www . radiantinsights . com / research / dry-eyesyndrome-china-drug-forecast-and-market-analysis-to-2024
8.1.2 Key Events 141 8.1.3 Drivers and Barriers 141
9 Appendix 142 9.1 Bibliography 142 9.2 Abbreviations 175 9.3 Methodology 180 9.4 Forecasting Methodology 180 9.4.1 Diagnosed DES Patients 180 9.4.2 Percent Drug-Treated Patients 180 9.4.3 Launch Dates 181